These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17918737)

  • 1. Formulating poly(lactide-co-glycolide) particles for plasmid DNA delivery.
    Abbas AO; Donovan MD; Salem AK
    J Pharm Sci; 2008 Jul; 97(7):2448-61. PubMed ID: 17918737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design, fabrication, characterization and in vitro testing of biodegradable microparticles that generate targeted and sustained transgene expression in HepG2 liver cells.
    Intra J; Salem AK
    J Drug Target; 2011 Jul; 19(6):393-408. PubMed ID: 20681752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic poly(lactide-co-glycolide) nanoparticles as efficient in vivo gene transfection agents.
    Kumar MN; Mohapatra SS; Kong X; Jena PK; Bakowsky U; Lehr CM
    J Nanosci Nanotechnol; 2004 Nov; 4(8):990-4. PubMed ID: 15656192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
    Zeng P; Xu Y; Zeng C; Ren H; Peng M
    Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(L-lactide-co-glycolide) nanospheres conjugated with a nuclear localization signal for delivery of plasmid DNA.
    Jeon O; Lim HW; Lee M; Song SJ; Kim BS
    J Drug Target; 2007 Apr; 15(3):190-8. PubMed ID: 17454356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained release of PEG-g-chitosan complexed DNA from poly(lactide-co-glycolide).
    Yun YH; Jiang H; Chan R; Chen W
    J Biomater Sci Polym Ed; 2005; 16(11):1359-78. PubMed ID: 16372401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
    Dong Y; Feng SS
    Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface modified poly(β amino ester)-containing nanoparticles for plasmid DNA delivery.
    Fields RJ; Cheng CJ; Quijano E; Weller C; Kristofik N; Duong N; Hoimes C; Egan ME; Saltzman WM
    J Control Release; 2012 Nov; 164(1):41-8. PubMed ID: 23041278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preparation and in vitro release characteristics of curcumin loaded biodegradable microspheres].
    Wang H; Li P; Zhang L; Zhang J; Ling X; Ran H
    Zhongguo Zhong Yao Za Zhi; 2009 Dec; 34(23):3021-4. PubMed ID: 20222415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advance in the study of poly(lactide-co-glycolide) nano/microparticles as gene vector].
    Zeng P; Peng ML; Xu Y
    Yao Xue Xue Bao; 2010 Nov; 45(11):1346-53. PubMed ID: 21361033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles.
    Gargouri M; Sapin A; Arıca-Yegin B; Merlin JL; Becuwe P; Maincent P
    Int J Pharm; 2011 Jan; 403(1-2):276-84. PubMed ID: 21044878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA.
    Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
    Pharm Res; 1999 Apr; 16(4):509-13. PubMed ID: 10227704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ganciclovir on the hydrolytic degradation of poly(lactide-co-glycolide) microspheres.
    Chen X; Ooi CP; Lim TH
    J Biomater Appl; 2006 Jan; 20(3):287-302. PubMed ID: 16364967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adriamycin release from poly(lactide-coglycolide)-polyethylene glycol nanoparticles: synthesis, and in vitro characterization.
    Davaran S; Rashidi MR; Pourabbas B; Dadashzadeh M; Haghshenas NM
    Int J Nanomedicine; 2006; 1(4):535-9. PubMed ID: 17722284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo validation of biological responses of bFGF released from microspheres formulated by blending poly-lactide-co-glycolide and poly(ethylene glycol)-grafted-chitosan in hamster cheek pouch microcirculatory models.
    Falabella CA; Jiang H; Frame MD; Chen W
    J Biomater Sci Polym Ed; 2009; 20(7-8):903-22. PubMed ID: 19454159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles.
    Packhaeuser CB; Kissel T
    J Control Release; 2007 Nov; 123(2):131-40. PubMed ID: 17854938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(lactide-co-glycolide)-methoxy-poly(ethylene glycol) nanoparticles: drug loading and release properties.
    Katsikogianni G; Avgoustakis K
    J Nanosci Nanotechnol; 2006; 6(9-10):3080-6. PubMed ID: 17048521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and in vitro evaluation of surface-modified poly (lactide-co-glycolide) microparticles as biodegradable drug carriers for pulmonary peptide and protein delivery.
    Devrim B; Bozkır A
    J Microencapsul; 2014; 31(4):355-62. PubMed ID: 24697171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative degradation study of biodegradable microspheres of poly(DL-lactide-co-glycolide) with poly(ethyleneglycol) derivates.
    Garcia JT; Fariña JB; Munguía O; Llabrés M
    J Microencapsul; 1999; 16(1):83-94. PubMed ID: 9972505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.